Evidence map›Paper›PMID 32811892›Full record

ArticleScientific reports2020

Characterization of immune response induced against catalytic domain of botulinum neurotoxin type E.

Priyanka Sonkar, Vinita Chauhan, Ritika Chauhan, Nandita Saxena, Ram Kumar Dhaked

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Priyanka SonkarBiotechnology Division, Defence Research and Development Establishment, Gwalior, MP, 474002, India.
Vinita ChauhanBiotechnology Division, Defence Research and Development Establishment, Gwalior, MP, 474002, India.
Ritika ChauhanBiotechnology Division, Defence Research and Development Establishment, Gwalior, MP, 474002, India.
Nandita SaxenaToxicology and Pharmacology Division, Defence Research and Development Establishment, Gwalior, MP, 474002, India.
Ram Kumar DhakedBiotechnology Division, Defence Research and Development Establishment, Gwalior, MP, 474002, India. ramkumardhaked@hotmail.com.
Defence Research and Development Establishment · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Botulinum neurotoxins (BoNTs) represent a family of bacterial toxins responsible for neuroparalytic disease 'botulism' in human and animals. Their potential use as biological weapon led to their classification in category 'A' biowarfare agent by Centers for Disease Control and Prevention (CDC), USA. In present study, gene encoding full length catalytic domain of BoNT/E-LC was cloned, expressed and protein was purified using Ni-NTA chromatography. Humoral immune response was confirmed by Ig isotyping and cell-mediated immunity by cytokine profiling and intracellular staining for enumeration of IFN-γ secreting CD4

Indexed as

AnimalsAntibodies, NeutralizingBotulinum ToxinsBotulinum Toxins, Type ABotulismCatalytic DomainCD8-Positive T-LymphocytesCloning, MolecularClostridium botulinumHumansImmunizationMaleMiceMice, Inbred BALB CAntibodies, NeutralizingBotulinum ToxinsBotulinum Toxins, Type Abotulinum toxin type E

Identifiers

PMID32811892
PMCPMC7434876
OpenAlexW3054313352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.